First Time Loading...

Shanghai Medicilon Inc
SSE:688202

Watchlist Manager
Shanghai Medicilon Inc Logo
Shanghai Medicilon Inc
SSE:688202
Watchlist
Price: 35.36 CNY -1.81% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one Shanghai Medicilon Inc stock under the Base Case scenario is 75.64 CNY. Compared to the current market price of 35.36 CNY, Shanghai Medicilon Inc is Undervalued by 53%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
75.64 CNY
Undervaluation 53%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3
P/S
P/S
Price to Sales
3
vs History
94
vs Industry
58
Median 3Y
16.8
Median 5Y
13.4
Industry
3.9
Forward
2.9
More Details
27.2
P/E
P/E
Price to Earnings
27.2
vs History
92
vs Industry
26
Median 3Y
74.7
Median 5Y
70.7
Industry
31.1
Forward
26.5
More Details
274.7
P/OCF
P/OCF
Price to OCF
274.7
vs History
17
vs Industry
0
Median 3Y
129.8
Median 5Y
69.3
Industry
23.3
More Details
74.3
P/FCFE
P/FCFE
Price to FCFE
74.3
vs History
55
vs Industry
11
Median 3Y
146.6
Median 5Y
91.1
Industry
27.4
More Details
1.8
P/B
P/B
Price to Book Value
1.8
vs History
94
vs Industry
59
Median 3Y
15.9
Median 5Y
8.7
Industry
2.5
More Details
2.6
EV/S
EV/S
Enterprise Value to Sales
2.6
vs History
94
vs Industry
60
Median 3Y
16.6
Median 5Y
12.7
Industry
3.8
Forward
2.5
More Details
8.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.2
vs History
94
vs Industry
43
Median 3Y
37.8
Median 5Y
34
Industry
7.9
More Details
23.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
23.2
vs History
94
vs Industry
19
Median 3Y
64.8
Median 5Y
63.8
Industry
17.2
Forward
4.3
More Details
23.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23.2
vs History
94
vs Industry
25
Median 3Y
64.8
Median 5Y
63.8
Industry
22.7
More Details
236.3
EV/OCF
EV/OCF
Enterprise Value to OCF
236.3
vs History
17
vs Industry
1
Median 3Y
129.5
Median 5Y
68
Industry
21.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-14.5
Median 5Y
-18
Industry
27.9
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
94
vs Industry
50
Median 3Y
15.1
Median 5Y
12.1
Industry
2.4
More Details

Multiples Across Competitors

Competitors Multiples
Shanghai Medicilon Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Medicilon Inc
SSE:688202
4.8B CNY 3 27.2 23.2 23.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.3B USD 5.2 36.9 22.8 33.4
US
Danaher Corp
NYSE:DHR
184B USD 4.2 22.8 16.6 20.4
CH
Lonza Group AG
SIX:LONN
37.5B CHF 5.6 57.3 19.7 28.9
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD 2.7 29.9 16.3 25.2
US
Agilent Technologies Inc
NYSE:A
40.9B USD 6.1 33.1 26.4 31.8
KR
Samsung Biologics Co Ltd
KRX:207940
54.9T KRW 14.9 64 33.7 48.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.2 23.9 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
26.6B USD 9.1 46.9 32.5 39.5
IE
ICON PLC
NASDAQ:ICLR
25.6B USD 3.1 37.4 16.9 26
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 7.1 75.4 32.4 53.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.